Induction of PPAR gamma mRNA and protein expression by rosiglitazone in chronic cyclosporine nephropathy in the rat

Yonsei Medical Journal

Volumn 48, Issue 2, 2007, Pages 308-316

  Ahn, Kyung Ohk ^a   Lim, Sun Woo ^a   Yang, Hyun Joo ^a   Li, Can ^a,b   Sugawara, Akira ^c   Ito, Sadayoshi ^c   Choi, Bum Soon ^a   Kim, Yong Soo ^a   Kim, Jin ^a   Yang, Chul Woo ^a,d  

^a The Catholic University of Korea   (South Korea)

^b YANBIAN UNIVERSITY MEDICAL COLLEGE   (China)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d The Catholic University of Korea   (South Korea)

Author keywords

Cyclosporine; PPAR gamma; Rosiglitazone

Indexed keywords

CYCLOSPORIN A; MESSENGER RNA; OLIVE OIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DRUG MECHANISM; FEEDING; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; KIDNEY COLLECTING TUBULE; KIDNEY DISTAL TUBULE; KIDNEY EPITHELIUM; MALE; NEPHROTOXICITY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; KIDNEY DISEASES; MALE; PPAR GAMMA; PROTEIN BIOSYNTHESIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THIAZOLIDINEDIONES; TRANSCRIPTION, GENETIC;

EID: 34248231979     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2007.48.2.308     Document Type: Article

References (25)

1. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 1996; 50:1089-100.
2. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984;311:699-705.
3. Campistol JM, Sacks SH. Mechanisms of nephrotoxicity. Transplantation 2000;69 (12 Suppl):S5-10.
4. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, et al. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995;6:1186-96.
5. Guan Y, Breyer MD. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. Kidney Int 2001;60:14-30.
6. Sato K, Sugawara A, Kudo M, Uruno A, Ito S, Takeuchi K. Expression of peroxisome proliferator-activated receptor isoform proteins in the rat kidney. Hypertens Res 2004;27:417-25.
7. Buckingham RE, Al-Barazanji KA, Toseland CD, Slaughter M, Connor SC, West A, et al. Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes 1998; 47:1326-34.
8. Yue Tl TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, et al. In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 2001;104:2588-94.
9. Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J 2002,161:1027-40.
10. Chung BH, Li C, Sun BK, Lim SW, Ahn KO, Yang JH, et al. Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats. Am J Transplant 2005;5:1856-67.
11. Sugawara A, Yen PM, Qi Y, Lechan RM, Chin WW. Isoform-specific retinoid-X receptor (RXR) antibodies detect differential expression of RXR proteins in the pituitary gland. Endocrinology 1995;136:1766-74.
12. Lim SW, Li C, Sun BK, Han KH, Kim WY, Oh YW, et al. Long-term treatment with cyclosporine decreases aquaporins and urea transporters in the rat kidney. Am J Physiol Renal Physiol 2004;287:F139-51.
13. Yang CW, Ahn HJ, Kim WY, Li C, Jung JY, Yoon SA, et al. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy. Transplantation 2003;75:309-15.
14. Yang T, Michele DE, Park J, Smart AM, Lin Z, Brosius FC 3rd, et al. Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney. Am J Physiol 1999;277:F966-73.
15. Healy E, Dempsey M, Lally C, Ryan MP. Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line. Kidney Int 1998;54:1955-66.
16. Kim SI, Song HY, Hwang JH, Chong DL, Lee HY, Han DS, et al. Cyclosporine nephrotoxicity: the mechanisms of cell injury by cyclosporine A in renal proximal tubular cells. Transplant Proc 2000;32:1621-2.
17. Hortelano S, Castilla M, Torres AM, Tejedor A, Bosca L. Potentiation by nitric oxide of cyclosporin A and FK506-induced apoptosis in renal proximal tubule cells. J Am Soc Nephrol 2000;11:2315-23.
18. Slattery C, Campbell E, McMorrow T, Ryan MP. Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. Am J Pathol 2005; 167:395-407.
19. McMorrow T, Gaffney MM, Slattery C, Campbell E, Ryan MP. Cyclosporine A induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. Nephrol Dial Transplant 2005; 20:2215-25.
20. Bone JM, Amara AB, Shenkin A, Hammad A, Sells RA, Alexander JL, et al. Calcineurin inhibitors and proximal renal tubular injury in renal transplant patients with proteinuria and chronic allograft nephropathy. Transplantation 2005;79:119-22.
21. Yang CW, Ahn HJ, Kim WY, Shin MJ, Kim SK, Park JH, et al. Influence of the renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney. Kidney Int 2001;60: 847-57.
22. Sugawara A, Uruno A, Kudo M, Ikeda Y, Sato K, Taniyama Y, et al. Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells. J Biol Chem 2002;277: 9676-83.
23. Darlametsos IE, Papanikolaou EN, Varonos DD. Effect of nifedipine in cyclosporine-induced nephrotoxicity in rats: roles of the thromboxane and endothelin systems. Prostaglandins Leukot Essent Fatty Acids 2000;63:263-9.
24. Darlametsos IE, Varonos DD. Role of prostanoids and endothelins in the prevention of cyclosporine-induced nephrotoxicity. Prostaglandins Leukot Essent Fatty Acids 2001;64:231-9.
25. Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DE, et al. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat Med 2005;11:861-6.